Biohit Oyj CEO Semi Korpela takes sick leave

Biohit Oyj Stock Exchange Release January 5, 2017 at 1:00 pm local time (EEST)
 

Starting from January 5, 2017 Biohit Oyj´s CEO Semi Korpela will take a sick leave of approximately one month related to pneumonia.

During Semi Korpela´s sick leave, his deputy will be Biohit Oyj`s CFO Niklas Nordström.

Board of Directors

Additional information:

Osmo Suovaniemi, Chairman of the Board of Directors
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com